Singapore Institute of Advanced Medicine Holdings Pte Ltd (SAM) and ProNova announced that ProNova has been selected by SAM as its partner to establish the first proton therapy facility in Singapore. The SC360 proton therapy system will be an ... PharmaBiz, 4 hours ago
ProNova SC360 Selected for New Proton Center in Biopolis Singapore - Franklin Credit Management Corporation, 1 day ago
ProNova : SC360 Selected for New Proton Center in Biopolis Singapore - 4 Traders, 1 day ago
More from: CNBC, Stock Nod...and 29 other sources
Active Ingredient: Neisseria meningitidis polysaccharide serogroups A, C, W-135 and Y Licence Holder: Glaxosmithkline Pte Ltd Date of Approval: 3 April 2014 Indications: Active immunisation of individuals from 12 months of age against ...Medical Grapevine, 5 days ago
Figure 8.1 Future Market Scenarios: Description Figure 8.2 Total Drying Market: Future Evolution under 'Bearish' Scenario, Short - Mid Term, 2013 - 2018 (USD Million) Figure 8.3 Total Drying Market: Future Evolution under 'Bearish' Scenario, ...Scottrade, 2 months ago
on your WebpageAdd Widget >Get your members hooked!